课题基金 / 基金详情

The metabolic effects of ghrelin on muscle, adipose and liver.

The metabolic effects of ghrelin on muscle, adipose and liver.
生长素释放肽对肌肉、脂肪和肝脏的代谢影响。
批准号:
RGPIN-2016-03908
负责人:
Dyck, David
金额:
$2.99万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-01-01 至 2018-12-31

项目摘要

项目成果

Dyck, David的其他基金

相似基金

相关文献

中文摘要
翻译
胃饥饿素是一种胃肽,以其促氧(食欲刺激)作用而闻名。血浆胃饥饿素浓度在进餐前急剧上升,在进食后下降。胃饥饿素以两种亚型存在,酰化(AG)和去酰化(DAG)胃饥饿素。AG被认为是生物活性形式的促氧作用,虽然DAG最近被证明对外周组织有代谢作用。AG是生长激素促分泌受体亚型1a (GHS-R1a)的配体,并启动生长激素(GH)的释放。许多研究表明,胃促生长素输注会损害血液中葡萄糖的清除;然而,这些研究使用的剂量范围很广,通常是非生理性的,并且无法区分生长素的直接作用和由于生长激素的继发性增加而产生的作用。据推测,胃饥饿素是一个重要机制的一部分,通过刺激生长激素释放,从而促进脂肪分解和血糖保存,在长时间禁食期间防止极端低血糖。令人惊讶的是,
英文摘要
Ghrelin is a gastric peptide best known for its orexigenic (appetite-stimulating) effects. Plasma ghrelin concentrations rise sharply prior to entrained mealtimes and decline following the consumption of food. Ghrelin exists as two isoforms, acylated (AG) and deacylated (DAG) ghrelin. AG is considered the bioactive form in terms of orexigenic actions, although DAG has recently been demonstrated to have metabolic effects on peripheral tissues. AG is a ligand for the growth hormone secretagogue receptor subtype 1a (GHS-R1a) and initiates growth hormone (GH) release. A number of studies suggest that ghrelin infusion impairs the clearance of glucose from the blood; however, these studies utilize a wide range of dosages which are often nonphysiological, and are unable to distinguish between the direct effects of ghrelin vs. those due to the secondary increase in GH. It has been postulated that ghrelin is part of an important mechanism to prevent extreme hypoglycemia during a prolonged fast by stimulating GH release and thereby facilitating lipolysis and the preservation of blood glucose. Surprisingly, the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of peripheral metabolism by ghrelin.
  • 批准号:
    RGPIN-2022-03425
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2022
  • 负责人:
    Dyck, David
  • 依托单位:
The metabolic effects of ghrelin on muscle, adipose and liver.
  • 批准号:
    RGPIN-2016-03908
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.99万
  • 财政年份:
    2021
  • 负责人:
    Dyck, David
  • 依托单位:
The metabolic effects of ghrelin on muscle, adipose and liver.
  • 批准号:
    RGPIN-2016-03908
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.99万
  • 财政年份:
    2020
  • 负责人:
    Dyck, David
  • 依托单位:
The metabolic effects of ghrelin on muscle, adipose and liver.
  • 批准号:
    RGPIN-2016-03908
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.99万
  • 财政年份:
    2019
  • 负责人:
    Dyck, David
  • 依托单位:
国内基金
海外基金
Dynamic Credit Rating with Feedback Effects
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    Christian Martin Hilpert
  • 依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
  • 批准号:
    82371825
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    占贞贞
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
  • 批准号:
    32371121
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    孔风
  • 依托单位: